November is ‘Intern Spotlight Month’ here at Health Action International (HAI), when we shine a light on the interns who make tremendous contributions to our team and the work we do with their fresh perspectives, new ideas, intellect and vivacious spirit. Each week throughout the month of November, we’ll introduce you to one of our interns from the past year who’ll explain the research they conducted during their internship,
Clinical trials are key to determining the safety and efficacy of medicines. But to do so, trials must be robust and ethical—and their full results must be reported publicly. Unfortunately, many trials are not meeting this criteria. More and more are being off-shored to developing countries where they can be conducted more cheaply and with questionable ethical standards.
Health Action International is, once again, pleased to be in Geneva this week attending the 69th World Health Assembly. If you will be there, too, please plan on attending a side event on ‘Achieving Affordable Access to Health Technologies’, which we are co-organising with the Medicines for Malaria Venture and Oxfam.
The event will be held on Tuesday,
Every year, snakebite kills 125,000 people around the world and gravely injures 2.7 million more. For the first time at a World Health Assembly (WHA) side event, leading venom and snakebite experts, government representatives and medicine policy experts will discuss global challenges, initiatives and strategies to reduce death and disability from snakebite envenoming—one of the world’s most tragic and neglected tropical diseases.